StellarQ is an innovative company providing cutting-edge solutions for the next generation treatment monitoring of chronic diseases through StellarQ software and research services. Treatment monitoring: The StellarQ software provides professionals and patients tools for monitoring treatment of chronic diseases. The software is built to provide medical professionals with a primary interface for chronic disease treatment monitoring that is integrated into an existing patient information system. Research services: StellarQ research services utilize a wide and extensive range of registry information, which provides a strong foundation for research. Its core strengths include high quality prospective data and a supplementary retrospective data set, which help support research. Additionally, StellarQ is included in the Finnish Current Care Guidelines (Käypä hoito) for monitoring MS treatment. Interested to hear more? Visit our website www.stellarq.fi or send our experts an email at info@stellarq.com.
Looking for a particular StellarQ Oy employee's phone or email?
The StellarQ Oy annual revenue was $5 million in 2026.
Markku Aittokallio is the CEO of StellarQ Oy.
10 people are employed at StellarQ Oy.
StellarQ Oy is based in Turku, Southwest Finland.
The NAICS codes for StellarQ Oy are [325, 3254, 32541, 32].
The SIC codes for StellarQ Oy are [283, 28].